Depo-Provera meningioma symptoms are now at the center of one of the fastest-growing mass torts in the country. Women who received the birth control shot are learning that certain neurological warning signs may point to a brain tumor. For example, persistent headaches, blurred vision, and seizures can all be red flags. In most cases, these tumors are slow-growing. However, ignoring the early Depo-Provera meningioma symptoms can delay diagnosis and treatment. This page explains what to watch for and where the litigation stands in 2026.
Complete a short case review to see whether your diagnosis, Depo-Provera use history, and records may fit current attorney screening criteria. Submitting information does not guarantee representation, compensation, or participation in any lawsuit or settlement.
What Is the Depo-Provera Meningioma Symptoms About?
Depo-Provera is an injectable contraceptive made by Pfizer. Its active ingredient is medroxyprogesterone acetate, a synthetic progestin. The shot is given every three months. Millions of women have used it since the 1990s. For many, it was a convenient birth control choice.
However, research has linked long-term use to meningioma. A meningioma is a tumor that forms in the tissue layers around the brain and spinal cord. Most are benign. Even so, they can press on the brain and cause serious harm. A March 2024 study published in the BMJ found a 5.56-fold higher meningioma risk for women who used the shot for more than one year.
The lawsuits claim Pfizer knew about this risk but failed to warn patients and doctors. As a result, plaintiffs say they were never told to monitor for Depo-Provera meningioma symptoms. In December 2025, the FDA finally approved a label update adding a meningioma warning. Defendants include Pfizer, Pharmacia LLC, and Pharmacia & Upjohn Company LLC.
Case Timeline
Last checked: July 23, 2026
- July 01, 2026 (Case Status): The JPML’s monthly statistics report listed 5,830 actions pending in MDL 3140, with the general-causation Rule 702/Daubert hearing rescheduled to late July 2026 because the settlement will not resolve every case. (Court Record)
- June 15, 2026 (Settlement): Judge Rodgers entered an order confirming that plaintiffs’ lead counsel and Pfizer, Pharmacia LLC, and Pharmacia & Upjohn had reached a global settlement in principle for eligible plaintiffs with pending MDL cases, with financial terms undisclosed and the first pilot trial deadlines vacated. (Court Record)
- March 16, 2025 (Other): Judge Rodgers appointed plaintiffs’ leadership, including lead counsel, a Plaintiffs’ Executive Committee, Steering Committee, and liaison counsel. (Court Record)
- February 07, 2025 (Case Status): The Judicial Panel on Multidistrict Litigation centralized the Depo-Provera meningioma lawsuits as MDL No. 3140 and transferred them to the Northern District of Florida before Judge M. Casey Rodgers. (Court Record)
MDL Case Status and Key Facts
The federal cases are consolidated in MDL No. 3140. The litigation sits in the U.S. District Court for the Northern District of Florida. Judge M. Casey Rodgers oversees the coordinated pretrial process. The MDL has grown rapidly through 2026.
| MDL Number | MDL No. 3140 |
|---|---|
| Presiding Judge | Hon. M. Casey Rodgers |
| Federal District | Northern District of Florida (Pensacola) |
| Approximate Case Count | Roughly 5,800 cases (mid-2026) |
| Bellwether Trial | Toney v. Pfizer, Dec. 7, 2026 — vacated after settlement talks |
| General Causation Hearing | Reset to July 27, 2026 (Pensacola) |
In June 2026, the MDL added roughly 1,700 new cases in a single month. That surge pushed the total near 5,800 filings. As a result, this became one of the ten largest active litigations in the U.S.
On June 15, 2026, Pfizer and plaintiffs’ leadership reached a global settlement in principle. Judge Rodgers then vacated the December bellwether trial. However, the financial terms have not been disclosed. The Daubert hearing was reset to July 27, 2026, and stays relevant for cases outside any settlement.
Who Qualifies for the Depo-Provera Meningioma Symptoms?
Eligibility depends on your use history and diagnosis. Typically, qualifying claimants used Depo-Provera CI (150 mg injection) or Depo-SubQ Provera 104. In most cases, attorneys look for at least one year of documented use. Longer use generally strengthens a claim.
You must also have a confirmed meningioma diagnosis. This usually comes from an MRI or CT scan. The key evidence includes pharmacy records, medical charts, and imaging reports. For example, these records help link the drug to your Depo-Provera meningioma symptoms and diagnosis.
Timing matters too. A person who noticed Depo-Provera meningioma symptoms and got scanned has stronger documentation. However, every case is different. A licensed attorney can review your records and confirm whether you may qualify. Do not assume you are excluded before speaking with counsel.
How to File a Depo-Provera Meningioma Symptoms Claim
Start by gathering your records. Collect pharmacy printouts, injection dates, and your meningioma imaging. Next, find a licensed attorney who handles pharmaceutical injury cases. Many offer free case reviews. In most cases, they work on a contingency basis.
Your lawyer files your case directly into MDL No. 3140 or in a proper federal court. You will then complete a Plaintiff Fact Sheet. This document outlines your use history, diagnosis, and Depo-Provera meningioma symptoms. Accuracy here is important, so review it carefully with counsel.
Watch the statute of limitations closely. Each state sets its own deadline to sue. Typically, the clock may start when you discovered the injury or its cause. As a result, waiting too long can bar your claim entirely. Speak with a licensed attorney promptly to protect your rights.
📨 Get Free Mass Tort Guides Alerts
Free · No spam · Unsubscribe anytime
Settlement Updates and What to Expect
The June 2026 settlement in principle was a major turning point. However, no dollar figures have been released. The parties are still working to memorialize the terms. Until they do, the framework remains unofficial and subject to change.
Bellwether trials usually help set settlement values. Here, the first bellwether was vacated before trial. Instead, the global settlement talks moved the litigation forward. The July 27, 2026 general-causation hearing still matters for any claims that fall outside a deal.
Individual payouts in mass torts vary widely. Several factors affect value. For example, tumor severity, surgery, length of drug use, and lost income all play a role. No one can promise a specific amount. You may be eligible for compensation, but final values depend on the settlement and your facts.
State-by-State Considerations
State law shapes how these claims proceed. Some states have strict damage caps and tort reform rules. Others follow more plaintiff-friendly deadlines. As a result, where you live can affect your case. A licensed attorney familiar with your state can explain the differences.
Filings come from across the country. States like California, Texas, Florida, New York, and Pennsylvania report notable plaintiff counts. For example, statute-of-limitations rules differ sharply among them. Reviewing your state guide with counsel helps you understand local timing and any caps on recovery.
Frequently Asked Questions
What are the first Depo-Provera meningioma symptoms to watch for?
Common early signs include persistent headaches, blurred or changing vision, and hearing loss. Some women also report seizures, memory issues, or numbness in the arms or legs. See a doctor promptly if these appear or worsen.
Does a meningioma diagnosis guarantee I will win my case?
No. A diagnosis is important, but it does not guarantee compensation. You must also link your use to your Depo-Provera meningioma symptoms with strong records. A licensed attorney can assess whether you may qualify.
Is it too late to file if I stopped the shot years ago?
Not necessarily. Some states start the deadline when you discover the injury or its cause. However, these rules are complex and vary by state. Contact a licensed attorney quickly to check your filing window.
Check If You May Qualify
Mass tort eligibility depends on your specific exposure, injuries, and the state where you live. A licensed mass tort attorney can evaluate your situation at no upfront cost — most work on contingency, meaning you pay nothing unless you recover compensation.
Official Sources & Resources
For verified mass tort and MDL information:
- JPML: jpml.uscourts.gov — official MDL statistics and transfer orders
- DOJ: justice.gov — settlement announcements and press releases
- FDA: fda.gov — drug recalls, warning letters, and safety alerts
- CDC: cdc.gov — health condition data and exposure guidelines
- EPA: epa.gov — environmental contamination data
- Cornell LII: law.cornell.edu — plain-English legal definitions
Content last reviewed July 2026. This is general educational information, not legal advice. If you notice outdated information, please contact us.
Related Guides
- All Active MDL Cases
- More in This Category
- Tort Reform by State — 50-State Comparison
- All 50 State Tort Reform Guides
- Mass Tort Explainers
- Demographic Guides
- Mass Tort Tips
- North Carolina Tort Reform Guide
- California Tort Reform Guide
- Illinois Tort Reform Guide
Attorney Advertising. The information on this page is provided for general informational purposes only and does not constitute legal advice. No attorney-client relationship is created by accessing or using this content. Every case is unique, and results depend on the specific facts and circumstances involved. Past settlement amounts and case outcomes do not guarantee similar results in your case. If you believe you have a legal claim, you should consult with a licensed attorney in your jurisdiction who can evaluate your specific situation.
Complete a short case review to see whether your diagnosis, Depo-Provera use history, and records may fit current attorney screening criteria. Submitting information does not guarantee representation, compensation, or participation in any lawsuit or settlement.
Important: Legal deadlines can be time sensitive and vary by state, diagnosis date, exposure history, and other facts. Submitting information through this website does not file a lawsuit, preserve your rights, create an attorney-client relationship, or guarantee that any attorney will contact or represent you. If you do not receive a response, or if you are unsure about a filing deadline, you should promptly contact a qualified attorney of your choice to discuss your specific situation.
About this page: MassTortInfo.com is an informational publishing platform and a marketing / referral platform. We are not a law firm, settlement administrator, claims administrator, or government agency, and we do not provide legal advice. No attorney-client relationship is created by using this site or submitting any form. Submitting a form does not guarantee representation, compensation, eligibility, or participation in any lawsuit or settlement. This page contains paid advertising, and we may be compensated if you submit a case review. See our Terms of Service, Privacy Policy, and Disclaimer & Advertising Disclosure.